Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Potassium chloride provides potassium ions, essential for maintenance of intracellular tonicity, nerve impulse conduction, muscle contraction, and acid-base balance. Dextrose 5% provides caloric support and may help prevent ketosis. Sodium chloride 0.33% provides sodium and chloride ions to maintain electrolyte balance and osmotic pressure.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
Intravenous infusion at a rate determined by serum potassium levels; typical maintenance: 10-20 mEq potassium per hour, not to exceed 40 mEq/hour; maximum daily dose: 200 mEq. Adjust based on patient's electrolyte status and renal function.
None Documented
None Documented
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
The terminal half-life is approximately 2-4 hours in patients with normal renal function. Clinical context: half-life extends significantly in renal impairment (e.g., up to 24-48 hours in oliguric patients) and is dependent on total body potassium stores and redistribution kinetics.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Potassium is primarily excreted renally (90%) with minor fecal (10%) losses. Renal elimination involves glomerular filtration and distal tubular secretion; 80-90% is reabsorbed, with excretion adjusted by aldosterone. In dextrose/saline, potassium excretion parallels sodium and water handling.
Category C
Category A/B
Electrolyte
Electrolyte